Search alternatives:
significantly improving » significantly improved (Expand Search), significantly improve (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
Showing 741 - 760 results of 5,501 for search '(( significant decrease decrease ) OR ( significantly improving decrease ))~', query time: 0.28s Refine Results
  1. 741
    Clinical diagnosis and abnormal signals of AEFIs(/10,000).

    Clinical diagnosis and abnormal signals of AEFIs(/10,000). by Chao Zhang (51048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 742
    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n 

    Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 743
    Weekly resistance training frequency over time for the DHA and placebo groups combined (n 

    Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 744
    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.

    Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 745
    Changes in reported rate of AEFIs in the pre-LAW and post-LAW period(/10000).

    Changes in reported rate of AEFIs in the pre-LAW and post-LAW period(/10000). by Chao Zhang (51048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 746
    Data.

    Data. by Chao Zhang (51048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 747
    Participant demographic and clinical characteristics.

    Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 748
    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic exercise recommendation on average during chemotherapy.

    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 749
    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), randomized controlled trial (RCT).

    Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 750
    Characteristics of AEFIs with JEV-L vaccine in the pre-LAW and post-LAW period.

    Characteristics of AEFIs with JEV-L vaccine in the pre-LAW and post-LAW period. by Chao Zhang (51048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 751
    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance training exercise recommendation on average during chemotherapy.

    Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 752
    Reporting rate of AEFI of JEV-L in Huzhou, Zhejiang province, 2014–2023 (/10,000).

    Reporting rate of AEFI of JEV-L in Huzhou, Zhejiang province, 2014–2023 (/10,000). by Chao Zhang (51048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 753
    Schematic representation of the study protocol.

    Schematic representation of the study protocol. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 754
    Baseline characteristics.

    Baseline characteristics. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 755
    Comparison within groups.

    Comparison within groups. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 756
    Comparison before and after the experiment in each group.

    Comparison before and after the experiment in each group. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 757
    Data ste.

    Data ste. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 758
    Comparison of data after the experiment.

    Comparison of data after the experiment. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 759
    Correlation diagram of each parameter in each group.

    Correlation diagram of each parameter in each group. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 760
    Recruitment process.

    Recruitment process. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: